title: [Cytoflavin in polychemotherapy of breast cancer].
abstract: The efficacy of cytoflavin as a supporting drug in the CAF chemotherapy of breast cancer was studied. It was estimated by the tolerability, the peripheric blood index dynamics, the patients general condition (Karnovsky Index) and the frequency of the side effects. For the immediate estimation of the polychemotherapy and cytoflavin effects on the cytoprotection natural system state, the dynamics of the glutathione metabolism and the lipid peroxidation in the erythrocytes was investigated.
authors.forename: V A
authors.initials: VA
authors.lastname: Kashuro
authors.forename: S I
authors.initials: SI
authors.lastname: Glushkov
authors.forename: S N
authors.initials: SN
authors.lastname: Zheregelia
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols; D001943:Breast Neoplasms / Q000188:drug therapy*; D004338:Drug Combinations; D005260:Female; D005486:Flavin Mononucleotide / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007290:Inosine Diphosphate / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009536:Niacinamide / Q000009:adverse effects / Q000627:therapeutic use*; D011788:Quality of Life; D013386:Succinates / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D004338:Drug Combinations; D013386:Succinates; C507879:cytoflavin; D009536:Niacinamide; D005486:Flavin Mononucleotide; D007290:Inosine Diphosphate